Month: December 2023

News Alert

HRSA Unveils Web Page with Patient Definition Compliance Resources, Guidance

December 14, 2023 Rich Daly, Editor in Chief Views

HRSA released a new web page with resources on the agency's 340B program patient definition and compliance guidelines.

In the wake of a high-profile federal court ruling casting doubt on the definition of eligible “patient” in the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Dispute Resolution Coming This Month, White House Says

December 14, 2023 Tom Mirga, Editor at Large Views

The White House plans to release a revised administrative dispute resolution process for the 340B program this month.

The federal 340B program remains on track to publish a final rule this month revising its administrative dispute resolution (ADR) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Minnesota Issues Draft Guidance Implementing 340B Provider Reporting Requirements

December 14, 2023 William Newton, Associate Editor/Senior Writer Views

The Minnesota Department of Health finalized guidance for the state's new annual 340B covered entity reporting requirements.

Stakeholder comments are due Tuesday on Minnesota’s recently published guidance to implement one of the nation’s first state laws requiring [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Michigan to Increase Medicaid Payment for 340B Hospitals, Adds Reporting Requirements

December 14, 2023 William Newton, Associate Editor/Senior Writer Views

The Michigan Department of Health and Human Services released a new 340B hospital billing and reporting rule.

At the start of 2024, Michigan 340B hospitals can bill the state at higher payment rates for outpatient drugs; later [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Novo Nordisk to Provide 340B Refunds on Hemophilia Drugs

December 14, 2023 Rich Daly, Editor in Chief Views

Novo Nordisk will issue 340B provider refunds for formulations of two hemophilia drugs, according to a HRSA manufacturer notice.

Novo Nordisk will issue its fifth round of refunds this year on prices charged to 340B providers. The latest are [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

House Passes Healthcare Bill with 340B Provider Reporting Requirements

December 12, 2023 William Newton, Associate Editor/Senior Writer Views

A sweeping healthcare package with 340B reporting provisions from Rep. Cathy McMorris Rodgers (R-Wash.) was passed by the House of Representatives.

The U.S. House of Representatives last night passed a sweeping healthcare package that would require 340B providers to publicly report [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Legislation ‘Is Coming’ to Address Contract Pharmacy Restrictions, Hospital Advocate Says

December 12, 2023 Rich Daly, Editor in Chief Views

Maureen Testoni, president and CEO of 340B Health, said she anticipates bipartisan legislation on drugmaker 340B contract pharmacy restrictions.

Months after it was expected, bipartisan legislation to prevent drugmaker restrictions on the use of contract pharmacies by 340B providers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Missouri State Senator to Reintroduce 340B Contract Pharmacy, PBM Protection Bill

December 12, 2023 William Newton, Associate Editor/Senior Writer Views

The Missouri state senate recently passed a 340B contract pharmacy access bill.

A Missouri state senator has filed to reintroduce a bill that would bar drugmaker 340B contract pharmacy restrictions and pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Wisconsin Assembly Bill Introduced to Bar PBM Practices Against 340B Providers

December 12, 2023 William Newton, Associate Editor/Senior Writer Views

Wisconsin lawmakers have introduced bills in both legislative chambers that would bar PBMs from differentially reimbursing providers on the basis of their 340B status.

Just a week after Wisconsin state senators introduced a bipartisan bill to bar disparate treatment of 340B providers by pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Drugmakers Highlight 340B Developments in Earnings Calls

December 12, 2023 Rich Daly, Editor in Chief Views

Jean-Jacques Bienaime, CEO of drugmaker BioMarin, discussed the impact of 340B on pharmaceutical sales during an investor earnings call.

Pharmaceutical company executives discussed a range of 340B-related developments in recent third quarter investor calls. An executive for BioMarin Pharmaceutical, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live